RAC3 and lung adenocarcinoma: The results explained that the high expression of UBE2C, UCHL1, TRAIP, TNNT1, TNNI3, and RAC3 were associated with poor overall survival of lung adenocarcinoma patients (p < 0.05; Figure 8).